Follow
Wolfgang Wick
Wolfgang Wick
Verified email at med.uni-heidelberg.de - Homepage
Title
Cited by
Cited by
Year
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group
PY Wen, DR Macdonald, DA Reardon, TF Cloughesy, AG Sorensen, ...
Journal of clinical oncology 28 (11), 1963-1972, 2010
40582010
Bevacizumab plus radiotherapy–temozolomide for newly diagnosed glioblastoma
OL Chinot, W Wick, W Mason, R Henriksson, F Saran, R Nishikawa, ...
New England Journal of Medicine 370 (8), 709-722, 2014
26742014
DNA methylation-based classification of central nervous system tumours
D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ...
Nature 555 (7697), 469-474, 2018
22912018
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma
D Sturm, H Witt, V Hovestadt, DA Khuong-Quang, DTW Jones, ...
Cancer cell 22 (4), 425-437, 2012
19592012
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
CA Opitz, UM Litzenburger, F Sahm, M Ott, I Tritschler, S Trump, ...
Nature 478 (7368), 197-203, 2011
18672011
Identifying the best machine learning algorithms for brain tumor segmentation, progression assessment, and overall survival prediction in the BRATS challenge
S Bakas, M Reyes, A Jakab, S Bauer, M Rempfler, A Crimi, RT Shinohara, ...
arXiv preprint arXiv:1811.02629, 2018
18352018
How to use and assess qualitative research methods
L Busetto, W Wick, C Gumbinger
Neurological Research and practice 2 (1), 14, 2020
16672020
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
C Hartmann, J Meyer, J Balss, D Capper, W Mueller, A Christians, ...
Acta neuropathologica 118, 469-474, 2009
13012009
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
W Wick, M Platten, C Meisner, J Felsberg, G Tabatabai, M Simon, ...
The lancet oncology 13 (7), 707-715, 2012
12182012
Glioma
M Weller, W Wick, K Aldape, M Brada, M Berger, SM Pfister, R Nishikawa, ...
Nature reviews Disease primers 1 (1), 1-18, 2015
11722015
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
M Weller, M van den Bent, M Preusser, E Le Rhun, JC Tonn, G Minniti, ...
Nature reviews Clinical oncology 18 (3), 170-186, 2021
11602021
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre …
R Stupp, ME Hegi, T Gorlia, SC Erridge, J Perry, YK Hong, KD Aldape, ...
The lancet oncology 15 (10), 1100-1108, 2014
10282014
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
ME Hegi, L Liu, JG Herman, R Stupp, W Wick, M Weller, MP Mehta, ...
Journal of clinical oncology 26 (25), 4189-4199, 2008
10242008
Short-course radiation plus temozolomide in elderly patients with glioblastoma
JR Perry, N Laperriere, CJ O’Callaghan, AA Brandes, J Menten, C Phillips, ...
New England Journal of Medicine 376 (11), 1027-1037, 2017
10202017
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo
S Fulda, W Wick, M Weller, KM Debatin
Nature medicine 8 (8), 808-815, 2002
10122002
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas
M Weller, M Van Den Bent, JC Tonn, R Stupp, M Preusser, ...
The lancet oncology 18 (6), e315-e329, 2017
10042017
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the …
C Hartmann, B Hentschel, W Wick, D Capper, J Felsberg, M Simon, ...
Acta neuropathologica 120, 707-718, 2010
9702010
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide
W Wick, C Hartmann, C Engel, M Stoffels, J Felsberg, F Stockhammer, ...
Journal of clinical oncology 27 (35), 5874, 2009
9672009
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ...
The Lancet Oncology 18 (10), 1373-1385, 2017
9652017
Brain tumour cells interconnect to a functional and resistant network
M Osswald, E Jung, F Sahm, G Solecki, V Venkataramani, J Blaes, S Weil, ...
Nature 528 (7580), 93-98, 2015
9392015
The system can't perform the operation now. Try again later.
Articles 1–20